Incretins: all 1,182 studies that test it
Page 1 of 12. Open to participants first (46), then studies with results posted, then the rest; newest registration first within each.
- Supplementation of Gut-brain Axis (GLP-1)-Activating Carbohydrates for Increasing Satiety in Adolescents With ObesityNot yet recruitingNCT07823452Phase 2
- Disease-modifying Efficacy of Sitagliptin Therapy in Early-stage Parkinson's DiseaseNot yet recruitingNCT07804381Phase 2
- Sun Yat-Sen Treatment Strategy for Enhancing Response in Muscle-invasive Bladder CancerRecruitingNCT07717242Phase 2
- Sitagliptin With Pembro in RCC and MelanomaRecruitingNCT07634380Phase 1
- The Effects of LEUVATE on Glycemia, Insulinemia, Aminoacidemia, and Protein Synthesis in GLP-1 RA-treated AdultsNot yet recruitingNCT07595575Not applicable
- Sitagliptin in Recurrent/Progressive Grade 4 GliomaRecruitingNCT07541781Phase 1
- Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 DiabetesEnrolling by invitationNCT07452913Phase 4
- Comparative Study Between (SGLT-2i) and (DPP-4i) in the Prevention of DICRecruitingNCT07436663Phase 4
- A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or ObeseRecruitingNCT07411560Phase 1
- Insulin-Mediated Glucose Uptake and Organ Perfusion Assessed by Total-Body PET During GIP and GLP-1 InfusionRecruitingNCT07398300Not applicable
- Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRCRecruitingNCT07365592Phase 1/2
- Combination Therapy for Alcohol Use DisorderNot yet recruitingNCT07249554Phase 2
- Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic ControlRecruitingNCT07244003Phase 4
- Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)RecruitingNCT07225816Phase 1
- Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 InhibitorsNot yet recruitingNCT07108985Phase 4
- Effectiveness of Microdosed GLP-1 in Improving Health, Quality of Life, and Longevity MeasuresEnrolling by invitationNCT07092605Early Phase 1
- Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)RecruitingNCT07029009Phase 2
- A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 GliomasRecruitingNCT07003542Phase 2
- The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 DiabetesRecruitingNCT06976619Phase 2
- Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin CombinationRecruitingNCT06862739Phase 4
- Liraglutide Treatment in Obese Infertile PCOS WomenRecruitingNCT06742710Phase 4
- Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOSRecruitingNCT06587698Not applicable
- A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 DiabetesNot yet recruitingNCT06559722Phase 3
- Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver DiseaseRecruitingNCT06501326Phase 4
- A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese SubjectsRecruitingNCT06449703Phase 1
- LIROH - Liraglutide for Obesity in HIVRecruitingNCT06438146Phase 4
- The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy IndividualsRecruitingNCT06419686Phase 1
- Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac SurgeryRecruitingNCT06361238Phase 3
- The Bioequivalence Study of Linagliptin 5 mg Film-coated Tablet in Healthy Thai VolunteersNot yet recruitingNCT06243809Phase 1
- The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot StudyRecruitingNCT06217848Early Phase 1
- Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and InfertilityNot yet recruitingNCT05952882Phase 3
- Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes MellitusRecruitingNCT05779644Not applicable
- Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 AnalogueRecruitingNCT05751720Phase 1/2
- POSE2.0 With GLP-1 Agonist for Obesity ManagementRecruitingNCT05705388Not applicable
- Effects of GH and Lirglutide on AgRPRecruitingNCT05681299Phase 4
- Exenatide Pharmacokinetics and Pharmacodynamics in Gestational DiabetesRecruitingNCT05482789Phase 4
- Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes MellitusRecruitingNCT05268237Phase 1/2
- Effects of Sitagliptin in Relatives of T1D PatientsNot yet recruitingNCT05219409Phase 2/3
- Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic SyndromeRecruitingNCT04575844Phase 4
- Sitagliptin for the Treatment of Type 2 DiabetesRecruitingNCT04495881Phase 4
- Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)RecruitingNCT03883412Phase 4
- Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)RecruitingNCT03087032Phase 4
- Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune DiabetesRecruitingNCT03011021Phase 1/2
- Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)RecruitingNCT02969798Not applicable
- Beta-cell Response to Incretin Hormones in Cystic FibrosisRecruitingNCT01851694Not applicable
- Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass SurgeryRecruitingNCT00992901Early Phase 1
- Anti-Diabetic Medications to Fight PD and LBDCompletedNCT06263673Phase 4Results posted
- Pharmacogenomics of GLP1 Receptor AgonistsTerminatedNCT05762744Phase 1Results posted
- Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic KneeCompletedNCT05419856Phase 1Results posted
- Exenatide for Treating Cocaine Use DisorderCompletedNCT04941521Phase 1/2Results posted
- Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve GastrectomyCompletedNCT04883346Phase 2Results posted
- Liraglutide and Peripheral Artery DiseaseCompletedNCT04881110Phase 4Results posted
- Efficacy of Liraglutide Therapy in Patients With IPAATerminatedNCT04763564Phase 2Results posted
- EMI-EHP Weight Management and Type 2 Diabetes Pragmatic TrialTerminatedNCT04531176Phase 4Results posted
- To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus PatientsCompletedNCT04445714Phase 4Results posted
- Exenatide Once-weekly as a Treatment for Multiple System AtrophyCompletedNCT04431713Phase 2Results posted
- Use of a GLP-1R Agonist to Treat Opioid Use DisorderCompletedNCT04199728Phase 1/2Results posted
- A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 DiabetesCompletedNCT04017832Phase 3Results posted
- Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney TransplantationCompletedNCT03961256Phase 2Results posted
- Multiple Ascending Dose Study of AMG 598 in Adults With ObesityCompletedNCT03757130Phase 1Results posted
- Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1TerminatedNCT03738878Phase 4Results posted
- Daily Liraglutide for Nicotine DependenceCompletedNCT03712098Phase 2Results posted
- The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy DrinkersTerminatedNCT03645408Phase 1Results posted
- This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate PillsCompletedNCT03629054Phase 1Results posted
- Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in ObesityCompletedNCT03523273Phase 2Results posted
- A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian ParticipantsCompletedNCT03501277Phase 1Results posted
- Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.TerminatedNCT03500484Early Phase 1Results posted
- Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOSCompletedNCT03480022Phase 3Results posted
- Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TMCompletedNCT03429543Phase 3Results posted
- Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes PatientsCompletedNCT03359590Phase 2Results posted
- A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)TerminatedNCT03337698Phase 1/2Results posted
- Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in GlucosuriaCompletedNCT03331289Phase 4Results posted
- A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)TerminatedNCT03281369Phase 1/2Results posted
- Binge Eating Liraglutide InterventionTerminatedNCT03279731Phase 3Results posted
- An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on MetforminCompletedNCT03267576Phase 4Results posted
- Liraglutide Effects on Epicardial Fat Inflammatory GenesCompletedNCT03260881Phase 4Results posted
- This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the BloodCompletedNCT03259490Phase 1Results posted
- Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes MellitusCompletedNCT03231709Phase 4Results posted
- Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years OldCompletedNCT03199053Phase 3Results posted
- A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)CompletedNCT03175120Phase 3Results posted
- A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)CompletedNCT03172494Phase 3Results posted
- Bexagliflozin Drug/Drug Interaction Study With Exenatide InjectionCompletedNCT03167411Phase 1Results posted
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)CompletedNCT03158805Phase 2Results posted
- Effect of GLP-1 Receptor Agonism After Sleeve GastrectomyCompletedNCT03115424Phase 3Results posted
- Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes SubjectsCompletedNCT03115112Phase 3Results posted
- SNP Study of DPP-4 and GLP-1R in Chinese People (Including Diabetes Patients)CompletedNCT03108521Phase 4Results posted
- Cardiovascular Effects of GLP-1 Receptor ActivationCompletedNCT03101930Phase 4Results posted
- Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass SurgeryCompletedNCT03048578Phase 4Results posted
- Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese SubjectsCompletedNCT03041792Phase 1Results posted
- Impact of Liraglutide 3.0 on Body Fat DistributionCompletedNCT03038620Phase 4Results posted
- Saxenda in Obesity Services (STRIVE Study)CompletedNCT03036800Phase 4Results posted
- GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 DiabetesTerminatedNCT03029351Phase 4Results posted
- Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes MellitusCompletedNCT03010683Not applicableResults posted
- Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DMCompletedNCT02981069Phase 4Results posted
- Exenatide Once Weekly for Smoking CessationCompletedNCT02975297Phase 1/2Results posted
- LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.CompletedNCT02964247Phase 3Results posted
- Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist SettingCompletedNCT02963935Phase 3Results posted
- Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal InsulinCompletedNCT02963922Phase 3Results posted
- An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 DiabetesCompletedNCT02962492Not applicableResults posted
- Title: Therapeutic Targets in African-American Youth With Type 2 DiabetesCompletedNCT02960659Phase 1/2Results posted